Phase IIB/III Of TG4010 Immunotherapy In Patients With Stage IV Non-Small Cell Lung Cancer (TIME)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01383148
Recruitment Status : Terminated
First Posted : June 28, 2011
Last Update Posted : January 5, 2017
Information provided by (Responsible Party):